A carregar...
A236 METRONIDAZOLE IN THE TREATMENT OF RECURRENT HEPATIC ENCEPHALOPATHY: A CASE SERIES.
BACKGROUND: Hepatic encephalopathy (HE) affects 50–70% of cirrhotic patients. Lactulose is first-line therapy in HE prevention and in preventing recurrent HE. Rifaximin (RIF) is the next therapeutic choice for HE prevention after two recurrent HE episodes despite lactulose treatment. RIF has been su...
Na minha lista:
| Publicado no: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507794/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|